Start Preamble
Start Printed Page 28621
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is announcing that a collection of information entitled, “Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Start Further Info
FOR FURTHER INFORMATION CONTACT:
FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.
End Further Info
End Preamble
Start Supplemental Information
SUPPLEMENTARY INFORMATION:
On January 08, 2015, the Agency submitted a proposed collection of information entitled, “Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring” to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0409. The approval expires on April 30, 2018. A copy of the supporting statement for this information collection is available on the Internet at http://www.reginfo.gov/public/do/PRAMain.
Start Signature
Dated: May 13, 2015.
Leslie Kux,
Associate Commissioner for Policy.
End Signature
End Supplemental Information
[FR Doc. 2015-12078 Filed 5-18-15; 8:45 am]
BILLING CODE 4164-01-P
